SMA
Seven Mile Advisory Portfolio holdings
AUM
$166M
This Quarter Return
+13.29%
1 Year Return
+21.49%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$115M
AUM Growth
+$115M
(+21%)
Cap. Flow
+$8.91M
Cap. Flow
% of AUM
7.73%
Top 10 Holdings %
Top 10 Hldgs %
45.5%
Holding
156
New
28
Increased
78
Reduced
25
Closed
6
Top Buys
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$615K |
| 2 |
Microsoft
MSFT
|
$329K |
| 3 |
Blackstone
BX
|
$302K |
| 4 |
NextEra Energy, Inc.
NEE
|
$276K |
| 5 |
Lam Research
LRCX
|
$275K |
Top Sells
| 1 |
AstraZeneca
AZN
|
$248K |
| 2 |
Gilead Sciences
GILD
|
$220K |
| 3 |
British American Tobacco
BTI
|
$206K |
| 4 |
Sanofi
SNY
|
$206K |
| 5 |
Unilever
UL
|
$204K |
Sector Composition
| 1 | Technology | 22.42% |
| 2 | Communication Services | 9.31% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 6.24% |
| 5 | Consumer Discretionary | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ambev
ABEV
$34.1B
| – | – |
-11,211
| Closed | -$28.9K |
|
|
152
AstraZeneca
AZN
$249B
| – | – |
-3,665
| Closed | -$248K |
|
|
153
British American Tobacco
BTI
$121B
| – | – |
-6,572
| Closed | -$206K |
|
|
154
Gilead Sciences
GILD
$140B
| – | – |
-2,941
| Closed | -$220K |
|
|
155
Sanofi
SNY
$121B
| – | – |
-3,845
| Closed | -$206K |
|